No E-news broadcast would be complete without a ‘let’s knock the pharmaceutical monster’ story – so here’s this week’s offering.
One pharmaceutical, Sun Pharmaceuticals, has been accused of marketing a cancer drug as an infertility treatment in India, for which it has not been licensed.
The company has been accused of illegally promoting and marketing its drug, letrozole, which has been licensed as a breast cancer treatment for postmenopausal women. But drug company representatives have told gynaecologists in India that it can also induce ovulation in infertile women.
The company is investigating the allegations, and has said the illegal promotion may be down to salesmen ‘going overboard’.
(Source: Monthly Index of Medical Specialties India, September 2003).